PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1464679
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1464679
Adipose Derived Stem Cell Market, By Type, By Product Type, By Disease, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Adipose Derived Stem Cell Market size was valued at USD 2,144.5 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.
Adipose-derived stem cells (ADSCs) possess the ability to sustain self-renewal and exhibit an enhanced potential for multiple types of differentiation. This is achieved through the secretion of diverse paracrine factors and extracellular vesicles, enabling them to effectively restore impaired organs and tissues. As a result, there has been a growing focus on utilizing ADSCs in the fields of tissue engineering and organ regeneration. Obtaining ADSCs in substantial quantities is relatively straightforward, as they can be acquired through minimally invasive techniques like liposuction. This accessibility renders them an appealing source for applications in regenerative medicine and tissue engineering. Extensive research has been conducted to explore their therapeutic potential in addressing various medical conditions, including tissue repair, wound healing, and the regeneration of damaged or diseased tissues.
Adipose Derived Stem Cell Market- Market Dynamics
Rising demand for minimally invasive cosmetic procedures is anticipated to fuel market growth
Liposuction, which is a commonly used procedure for harvesting adipose tissue for ADSC isolation, is contributing to the availability of adipose tissue for ADSC-based therapies. The American Society of Plastic Surgeons (ASPS) reported that nearly 18 million individuals underwent surgical and minimally invasive cosmetic procedures in the United States in 2018, indicating a rising trend. This growth in the market is also creating opportunities for companies to commercialize ADSC-based products and therapies. However, it is important to note that safety concerns may pose restrictions on the market's expansion.
Adipose Derived Stem Cell Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)
Based on Type segmentation, Allogeneic Stem Cells were predicted to show maximum market share in the year 2023
Based on region, North America was the leading revenue generator in 2023
Adipose Derived Stem Cell Market- Segmentation Analysis:
The Global Adipose Derived Stem Cell Market is segmented based on Type, Product Type, Disease, Technology and Region.
The market is categorized into two groups according to Type: Autologous Stem Cells and Allogeneic Stem Cells. Allogeneic Stem Cells hold the majority share in the market. The combination of adipose-derived stem cells and allogeneic stem cells is a significant field of study and advancement in regenerative medicine. These sources of stem cells provide distinct benefits and are currently under investigation for their potential in treating various diseases and medical conditions.
The market is segmented into four groups according to Product Type: Cell line, Culture media, Media, Sera, and Reagents. The market for adipose-derived stem cells includes a wide range of products, such as cell lines, culture media, sera, and reagents, all of which are essential for driving progress in research, development, and commercialization within the regenerative medicine sector.
The market is segmented into eight categories according to Disease: Cancer, Obesity, Wounds and Injuries, Musculoskeletal Diseases, Cardiovascular Diseases, Central Nervous System Diseases, Metabolic Diseases, Gastro-intestinal Diseases, and Other conditions. Adipose-derived stem cells are highly versatile and possess regenerative capabilities, positioning them as promising candidates for innovative therapies in a wide range of medical fields.
The market is categorized into three groups based on End-User: Cell banks & tissue banks, Research laboratories and Academic institutes, Hospitals and Trauma centers and Others. It is imperative for collaboration and interdisciplinary efforts among these stakeholders to drive advancements in the field of regenerative medicine and facilitate the translation of ADSC-based therapies into clinical practice.
Adipose Derived Stem Cell Market- Geographical Insights
Geographically, this market is extensively spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further categorized based on the countries involved in business activities. The market is predominantly dominated by North America, primarily due to the growing number of research and development initiatives undertaken by various organizations. Notably, government agencies in North America, such as the National Institutes of Health (NIH) in the U.S., play a significant role by providing substantial funding for stem cell research. This financial support greatly accelerates research and development efforts, fosters innovation, and contributes to advancements in understanding ADSC biology and therapeutic applications. In 2019, the United States witnessed a remarkable research and experimental development (R&D) performance, reaching USD 667 billion, and it is estimated to have further increased to USD 708 billion in 2020, as reported by the National Science Foundation. Europe holds the second-largest region for market growth, primarily driven by the increasing consumer awareness of regenerative medicine.
Adipose Derived Stem Cell Market- Competitive Landscape:
The competitive landscape of the market for adipose-derived stem cells (ADSC) is shaped by the growing awareness of the therapeutic benefits of ADSCs in different medical fields. Businesses aim to set themselves apart by creating unique products and technologies for the isolation, expansion, and application of ADSCs in both research and clinical settings. They are also looking to broaden their reach in the ADSC market by venturing into new regions, forming partnerships with distributors, and focusing on emerging areas like regenerative aesthetics and veterinary medicine. Strategies for market expansion may involve obtaining regulatory approvals, launching market access initiatives, and forming strategic partnerships with influential figures in the healthcare industry.
Recent Developments:
In October 2023, as per Takeda's announcement, the Phase 3 ADMIRE-CD II research, which evaluated the safety and effectiveness of Alofisel(R) (darvadstrocel) in treating complex Crohn's Perianal Fistulas (CPF), failed to achieve its primary goal of combined remission at 24 weeks, according to topline results. Nothing new was found in terms of safety signals, and darvadstrocel's safety profile matched that of earlier research.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL Adipose Derived Stem Cell MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
AlloCure
Antria
Celgene Corporation
Cellleris
Corestem
Cytori Therapeutics
Intrexon
Mesoblast
Pluristem Therapeutics
Tissue Genesis
BioRestorative Therapies
Celltex Therapeutics Corporation
iXCells Biotechnologies
Cyagen
Lonza
Others
GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Autologous Stem Cells
- Allogeneic Stem Cells
GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Cell line
- Culture media
- Media
- Sera
- Reagents
GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032
- Cancer
- Obesity
- Wounds and Injuries
- Musculoskeletal Diseases
- Cardiovascular Diseases
- Central Nervous System Diseases
- Metabolic Diseases
- Gastro-intestinal Diseases
- Others
GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Cell banks & tissue banks
- Research laboratories and Academic institutes
- Hospitals and Trauma centers
- Other
GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1.Adipose Derived Stem CellMarket Overview
- 1.1.Study Scope
- 1.2.Market Estimation Years
2.Executive Summary
- 2.1.Market Snippet
- 2.1.1.Adipose Derived Stem CellMarket Snippet by Type
- 2.1.2.Adipose Derived Stem CellMarket Snippet by Product Type
- 2.1.3.Adipose Derived Stem CellMarket Snippet by Disease
- 2.1.4.Adipose Derived Stem CellMarket Snippet by End-User
- 2.1.5.Adipose Derived Stem CellMarket Snippet by Country
- 2.1.6.Adipose Derived Stem CellMarket Snippet by Region
- 2.2.Competitive Insights
3.Adipose Derived Stem CellKey Market Trends
- 3.1.Adipose Derived Stem CellMarket Drivers
- 3.1.1.Impact Analysis of Market Drivers
- 3.2.Adipose Derived Stem CellMarket Restraints
- 3.2.1.Impact Analysis of Market Restraints
- 3.3.Adipose Derived Stem CellMarket Opportunities
- 3.4.Adipose Derived Stem CellMarket Future Trends
4.Adipose Derived Stem CellIndustry Study
- 4.1.PEST Analysis
- 4.2.Porter's Five Forces Analysis
- 4.3.Growth Prospect Mapping
- 4.4.Regulatory Framework Analysis
5.Adipose Derived Stem CellMarket: COVID-19 Impact Analysis
- 5.1.Pre-COVID-19 Impact Analysis
- 5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments
6.Adipose Derived Stem CellMarket Landscape
- 6.1.Adipose Derived Stem CellMarket Share Analysis, 2023
- 6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis
7.Adipose Derived Stem CellMarket - By Type
- 7.1.Overview
- 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2.Autologous Stem Cells
- 7.1.3.Allogeneic Stem Cells
8.Adipose Derived Stem CellMarket - By Product Type
- 8.1.Overview
- 8.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 8.1.2.Cell line
- 8.1.3.Culture media
- 8.1.4.Media
- 8.1.5.Sera
- 8.1.6.Reagents
9.Adipose Derived Stem CellMarket - By Disease
- 9.1.Overview
- 9.1.1.Segment Share Analysis, By Disease, 2023 & 2032 (%)
- 9.1.2.Cancer
- 9.1.3.Obesity
- 9.1.4.Wounds and Injuries
- 9.1.5.Musculoskeletal Diseases
- 9.1.6.Cardiovascular Diseases
- 9.1.7.Central Nervous System Diseases
- 9.1.8.Metabolic Diseases
- 9.1.9.Gastro-intestinal Diseases
- 9.1.10.Others
10.Adipose Derived Stem CellMarket - By End-User
- 10.1.Overview
- 10.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 10.1.2.Cell banks & tissue banks
- 10.1.3.Research laboratories and Academic institutes
- 10.1.4.Hospitals and Trauma centers
- 10.1.5.Other
11.Adipose Derived Stem CellMarket- By Geography
- 11.1.Introduction
- 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 11.2.North America
- 11.2.1.Overview
- 11.2.2.Adipose Derived Stem CellKey Manufacturers in North America
- 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.2.5.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.6.North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.2.7.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8.U.S.
- 11.2.8.1.Overview
- 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.2.8.4.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.8.5.U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.2.8.6.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9.Canada
- 11.2.9.1.Overview
- 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.2.9.4.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.9.5.Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.2.9.6.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.Europe
- 11.3.1.Overview
- 11.3.2.Adipose Derived Stem CellKey Manufacturers in Europe
- 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.5.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.6.Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.7.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8.Germany
- 11.3.8.1.Overview
- 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.8.4.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.8.5.Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.8.6.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9.Italy
- 11.3.9.1.Overview
- 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.9.4.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.9.5.Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.9.6.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10.United Kingdom
- 11.3.10.1.Overview
- 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.10.4.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.10.5.United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.10.6.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11.France
- 11.3.11.1.Overview
- 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.11.4.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.11.5.France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.11.6.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12.Russia
- 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.12.3.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.12.4.Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.12.5.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13.Netherlands
- 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.13.3.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.13.4.Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.13.5.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14.Sweden
- 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.14.3.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.14.4.Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.14.5.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15.Poland
- 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.15.3.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.15.4.Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.15.5.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16.Rest of Europe
- 11.3.16.1.Overview
- 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.16.5.Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.16.6.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.Asia Pacific (APAC)
- 11.4.1.Overview
- 11.4.2.Adipose Derived Stem CellKey Manufacturers in Asia Pacific
- 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.5.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.6.Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.7.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8.India
- 11.4.8.1.Overview
- 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.8.4.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.8.5.India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.8.6.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9.China
- 11.4.9.1.Overview
- 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.9.4.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.9.5.China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.9.6.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10.Japan
- 11.4.10.1.Overview
- 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.10.4.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.10.5.Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.10.6.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11.South Korea
- 11.4.11.1.Overview
- 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.11.4.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.11.5.South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.11.6.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12.Australia
- 11.4.12.1.Overview
- 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.12.4.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.12.5.Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.12.6.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13.Thailand
- 11.4.13.1.Overview
- 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.13.4.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.13.5.Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.13.6.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14.Indonesia
- 11.4.14.1.Overview
- 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.14.4.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.14.5.Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.14.6.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15.Philippines
- 11.4.15.1.Overview
- 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.15.4.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.15.5.Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.15.6.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16.Rest of APAC
- 11.4.16.1.Overview
- 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.16.4.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.16.5.Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.16.6.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.Latin America
- 11.5.1.Overview
- 11.5.2.Adipose Derived Stem CellKey Manufacturers in Latin America
- 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.5.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.6.Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.7.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8.Brazil
- 11.5.8.1.Overview
- 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.8.4.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.8.5.Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.8.6.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9.Mexico
- 11.5.9.1.Overview
- 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.9.4.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.9.5.Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.9.6.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10.Argentina
- 11.5.10.1.Overview
- 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.10.4.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.10.5.Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.10.6.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11.Colombia
- 11.5.11.1.Overview
- 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.11.4.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.11.5.Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.11.6.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12.Rest of LATAM
- 11.5.12.1.Overview
- 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.12.5.Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.12.6.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.Middle East and Africa
- 11.6.1.Overview
- 11.6.2.Adipose Derived Stem CellKey Manufacturers in Middle East and Africa
- 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.5.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.6.Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.7.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8.Saudi Arabia
- 11.6.8.1.Overview
- 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.8.5.Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.8.6.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9.United Arab Emirates
- 11.6.9.1.Overview
- 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.9.5.United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.9.6.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10.Israel
- 11.6.10.1.Overview
- 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.10.4.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.10.5.Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.10.6.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11.Turkey
- 11.6.11.1.Overview
- 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.11.4.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.11.5.Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.11.6.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12.Algeria
- 11.6.12.1.Overview
- 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.12.4.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.12.5.Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.12.6.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13.Egypt
- 11.6.13.1.Overview
- 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.13.4.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.13.5.Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.13.6.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14.Rest of MEA
- 11.6.14.1.Overview
- 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.14.4.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.14.5.Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.14.6.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.Key Vendor Analysis- Adipose Derived Stem CellIndustry
- 12.1.Competitive Dashboard
- 12.2.Company Profiles
- 12.2.1.AlloCure
- 12.2.2.Antria
- 12.2.3.Celgene Corporation
- 12.2.4.Cellleris
- 12.2.5.Corestem
- 12.2.6.Cytori Therapeutics
- 12.2.7.Intrexon
- 12.2.8.Mesoblast
- 12.2.9.Pluristem Therapeutics
- 12.2.10.Tissue Genesis
- 12.2.11.BioRestorative Therapies
- 12.2.12.Celltex Therapeutics Corporation
- 12.2.13.iXCells Biotechnologies
- 12.2.14.Cyagen
- 12.2.15.Lonza
- 12.2.16.Others
13.360 Degree Analyst View
14.Appendix
- 14.1.Research Methodology
- 14.2.References
- 14.3.Abbreviations
- 14.4.Disclaimer
- 14.5.Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Adipose Derived Stem CellMarket: Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Type
- TABLE Global Adipose Derived Stem CellMarket, by Type 2019-2032 (USD Million)
- TABLE Adipose Derived Stem CellMarket: Product Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Product Type
- TABLE Global Adipose Derived Stem CellMarket, by Product Type 2019-2032 (USD Million)
- TABLE Adipose Derived Stem CellMarket: Disease Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Disease
- TABLE Global Adipose Derived Stem CellMarket, by Disease 2019-2032 (USD Million)
- TABLE Adipose Derived Stem CellMarket: End-User Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End-User
- TABLE Global Adipose Derived Stem CellMarket, by End-User 2019-2032 (USD Million)
- TABLE Adipose Derived Stem CellMarket: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Adipose Derived Stem CellMarket, by Region 2019-2032 (USD Million)
- TABLE North America Adipose Derived Stem CellMarket, by Country, 2019-2032 (USD Million)
- TABLE North America Adipose Derived Stem CellMarket, by Type, 2019-2032 (USD Million)
- TABLE North America Adipose Derived Stem CellMarket, by Product Type, 2019-2032 (USD Million)
- TABLE North America Adipose Derived Stem CellMarket, by Disease, 2019-2032 (USD Million)
- TABLE North America Adipose Derived Stem CellMarket, by End-User, 2019-2032 (USD Million)
- TABLE Europe Adipose Derived Stem CellMarket, by Country, 2019-2032 (USD Million)
- TABLE Europe Adipose Derived Stem CellMarket, by Type, 2019-2032 (USD Million)
- TABLE Europe Adipose Derived Stem CellMarket, by Product Type, 2019-2032 (USD Million)
- TABLE Europe Adipose Derived Stem CellMarket, by Disease, 2019-2032 (USD Million)
- TABLE Europe Adipose Derived Stem CellMarket, by End-User, 2019-2032 (USD Million)
- TABLE Asia Pacific Adipose Derived Stem CellMarket, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Adipose Derived Stem CellMarket, by Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Adipose Derived Stem CellMarket, by Product Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Adipose Derived Stem CellMarket, by Disease, 2019-2032 (USD Million)
- TABLE Asia Pacific Adipose Derived Stem CellMarket, by End-User, 2019-2032 (USD Million)
- TABLE Latin America Adipose Derived Stem CellMarket, by Country, 2019-2032 (USD Million)
- TABLE Latin America Adipose Derived Stem CellMarket, by Type, 2019-2032 (USD Million)
- TABLE Latin America Adipose Derived Stem CellMarket, by Product Type, 2019-2032 (USD Million)
- TABLE Latin America Adipose Derived Stem CellMarket, by Disease, 2019-2032 (USD Million)
- TABLE Latin America Adipose Derived Stem CellMarket, by End-User, 2019-2032 (USD Million)
- TABLE Middle East and Africa Adipose Derived Stem CellMarket, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Adipose Derived Stem CellMarket, by Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Adipose Derived Stem CellMarket, by Product Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Adipose Derived Stem CellMarket, by Disease, 2019-2032 (USD Million)
- TABLE Middle East and Africa Adipose Derived Stem CellMarket, by End-User, 2019-2032 (USD Million)
